Last reviewed · How we verify

vitamin B6 (pyridoxine)

Haukeland University Hospital · FDA-approved active Small molecule

Vitamin B6 (pyridoxine) acts as a coenzyme in amino acid metabolism, neurotransmitter synthesis, and hemoglobin formation.

Vitamin B6 (pyridoxine) acts as a coenzyme in amino acid metabolism, neurotransmitter synthesis, and hemoglobin formation. Used for Vitamin B6 deficiency, Homocysteinemia, Peripheral neuropathy.

At a glance

Generic namevitamin B6 (pyridoxine)
SponsorHaukeland University Hospital
Drug classVitamin B complex
TargetPyridoxal-5-phosphate-dependent enzymes
ModalitySmall molecule
Therapeutic areaNutritional/Metabolic
PhaseFDA-approved

Mechanism of action

Pyridoxine is converted to its active form, pyridoxal-5-phosphate (PLP), which serves as a cofactor for over 100 enzymes involved in protein metabolism, neurotransmitter production (serotonin, dopamine, GABA), and immune function. It is essential for the synthesis of hemoglobin and myelin, and plays a critical role in homocysteine metabolism.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: